META vs. HALO
META (Meta Platforms, Inc.) and HALO (Halozyme Therapeutics, Inc.) are both stocks. META operates in Internet Content & Information (Communication Services), while HALO operates in Biotechnology (Healthcare). Over the past 10 years, META returned 17.39%/yr vs 22.84%/yr for HALO. At a 0.27 correlation, their price movements are largely independent.
Performance
META vs. HALO - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, META achieves a -14.03% return, which is significantly lower than HALO's 3.27% return. Over the past 10 years, META has underperformed HALO with an annualized return of 17.39%, while HALO has yielded a comparatively higher 22.84% annualized return.
META
- 1D
- -0.26%
- 1M
- -8.32%
- YTD
- -14.03%
- 6M
- -11.84%
- 1Y
- -16.71%
- 3Y*
- 28.18%
- 5Y*
- 11.52%
- 10Y*
- 17.39%
HALO
- 1D
- -1.74%
- 1M
- 0.42%
- YTD
- 3.27%
- 6M
- 11.72%
- 1Y
- 28.75%
- 3Y*
- 27.10%
- 5Y*
- 10.19%
- 10Y*
- 22.84%
META vs. HALO - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
META Meta Platforms, Inc. | -14.03% | 13.09% | 66.05% | 194.13% | -64.22% | 23.13% | 33.09% | 56.57% | -25.71% | 53.38% |
HALO Halozyme Therapeutics, Inc. | 3.27% | 40.77% | 29.36% | -35.04% | 41.51% | -5.85% | 140.89% | 21.19% | -27.79% | 105.06% |
Correlation
The correlation between META and HALO is 0.01, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.01 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.07 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.22 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.26 |
Correlation (All Time) Calculated using the full available price history since May 18, 2012 | 0.27 |
Over the past year, the correlation between META and HALO has dropped to 0.01 - well below their long-term average of 0.27, suggesting their price drivers have been diverging.
Fundamentals
META:
$1.45T
HALO:
$8.54B
META:
$27.47
HALO:
$2.87
META:
20.64
HALO:
24.26
META:
0.85
HALO:
2.74
META:
6.78
HALO:
5.61
META:
5.97
HALO:
38.88
META:
$214.96B
HALO:
$1.51B
META:
$176.14B
HALO:
$1.23B
META:
$106.31B
HALO:
$980.05M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
META vs. HALO — Risk / Return Rank
META
HALO
META vs. HALO - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Meta Platforms, Inc. (META) and Halozyme Therapeutics, Inc. (HALO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| META | HALO | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.42 | ||
| Sortino ratioReturn per unit of downside risk | -1.95 | ||
| Omega ratioGain probability vs. loss probability | 0.93 | 1.17 | -0.24 |
| Calmar ratioReturn relative to maximum drawdown | -0.54 | 1.14 | -1.68 |
| Martin ratioReturn relative to average drawdown | -1.12 | 2.16 | -3.28 |
Loading charts...
Drawdowns
META vs. HALO - Drawdown Comparison
The maximum META drawdown since its inception was -76.74%, roughly equal to the maximum HALO drawdown of -74.26%. Use the drawdown chart below to compare losses from any high point for META and HALO.
Loading charts...
Drawdown Indicators
| META | HALO | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -76.74% | -74.26% | -2.48% |
Max Drawdown (1Y)Largest decline over 1 year | -33.30% | -24.13% | -9.17% |
Max Drawdown (3Y)Largest decline over 3 years | -34.15% | -33.92% | -0.23% |
Max Drawdown (5Y)Largest decline over 5 years | -76.74% | -49.06% | -27.68% |
Max Drawdown (10Y)Largest decline over 10 years | -76.74% | -49.06% | -27.68% |
Current DrawdownCurrent decline from peak | -28.06% | -14.44% | -13.62% |
Average DrawdownAverage peak-to-trough decline | -15.83% | -31.88% | +16.05% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 16.06% | 12.73% | +3.33% |
Volatility
META vs. HALO - Volatility Comparison
Meta Platforms, Inc. (META) has a higher volatility of 10.17% compared to Halozyme Therapeutics, Inc. (HALO) at 8.94%. This indicates that META's price experiences larger fluctuations and is considered to be riskier than HALO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| META | HALO | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 10.17% | 8.94% | +1.23% |
Volatility (6M)Calculated over the trailing 6-month period | 26.91% | 24.02% | +2.89% |
Volatility (1Y)Calculated over the trailing 1-year period | 35.52% | 30.20% | +5.32% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 44.04% | 39.42% | +4.62% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 38.67% | 42.88% | -4.21% |
Dividends
META vs. HALO - Dividend Comparison
META's dividend yield for the trailing twelve months is around 0.37%, while HALO has not paid dividends to shareholders.
| Position | TTM | 2025 | 2024 |
|---|---|---|---|
HALO Halozyme Therapeutics, Inc. | 0.00% | 0.00% | 0.00% |
META Meta Platforms, Inc. | 0.37% | 0.32% | 0.34% |
Financials
META vs. HALO - Financials Comparison
This section allows you to compare key financial metrics between Meta Platforms, Inc. and Halozyme Therapeutics, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
META vs. HALO - Profitability Comparison
META - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Meta Platforms, Inc. reported a gross profit of 46.09B and revenue of 56.31B. Therefore, the gross margin over that period was 81.9%.
HALO - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Halozyme Therapeutics, Inc. reported a gross profit of 297.47M and revenue of 376.71M. Therefore, the gross margin over that period was 79.0%.
META - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Meta Platforms, Inc. reported an operating income of 22.87B and revenue of 56.31B, resulting in an operating margin of 40.6%.
HALO - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Halozyme Therapeutics, Inc. reported an operating income of 184.52M and revenue of 376.71M, resulting in an operating margin of 49.0%.
META - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Meta Platforms, Inc. reported a net income of 26.77B and revenue of 56.31B, resulting in a net margin of 47.5%.
HALO - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Halozyme Therapeutics, Inc. reported a net income of 150.05M and revenue of 376.71M, resulting in a net margin of 39.8%.
Frequently Asked Questions
META and HALO have a correlation of 0.01, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
META has higher volatility (10.17%) compared to HALO (8.94%). In terms of maximum drawdown, META dropped -76.74% vs HALO's -74.26%.
HALO currently has the higher Sharpe Ratio (0.91 vs -0.51), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for META and HALO
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer